Cover Image

Clinical and demographic characteristics associated with nail involvement in alopecia areata: A cross‐sectional study of 197 patients

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Safoura Shakoei, Golnoosh Seifi, Farbod Ghanami, Narges Ghandi, Shahin Hamzelou, Maryam Nasimi, Ifa Etesami
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Health Science Reports
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of 0.5% Timolol Maleate Eye Drops for the Treatment of Facial Rosacea: A Randomized, Triple‐Blind, Placebo‐Controlled Clinical Trial
by: Ali Moradi, et al.
Published: (2026)

Trichoscopic findings in children and adults with alopecia areata: A comparative study
by: Zeinab Aryanian, et al.
Published: (2024)

Evaluation of Demographic, Clinical, and Histological Characteristics of Spitz Nevus Among Iranian Patients: A Retrospective Study From 2016 to 2021
by: Zeinab Aryanian, et al.
Published: (2024)

Clinical and Histopathological Insights Into Lupus Miliaris Disseminatus Faciei: A Review of 70 Cases
by: Maryam Nasimi, et al.
Published: (2025)

Correction to “Sleep disturbance in alopecia areata: A cross‐sectional study”
Published: (2024)

Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
by: Robabeh Abedini, et al.
Published: (2024)

What is alopecia areata?
Published: (2025)

Successful treatment of alopecia areata‐associated trachyonychia with baricitinib
by: Petra Rózsa, et al.
Published: (2024)

Perspectives of patients with alopecia areata: a cross‐sectional analysis of YouTube and TikTok responses
by: Eric McMullen, et al.
Published: (2024)

Comparative study on sexual dysfunction in alopecia areata: prevalence and associated factors
by: Daniel Muñoz‐Barba, et al.
Published: (2024)

A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system
by: Advaitaa Ravipati, et al.
Published: (2024)

RETRACTED: Explore the genetic exposure to alopecia areata
by: Shaoyi Peng, et al.
Published: (2024)

Evaluation of quality of life scores and family impact scales in pediatric patients with alopecia areata: a cross‐sectional cohort study
by: Sera Nur Yücesoy, et al.
Published: (2024)

Patient satisfaction with multidisciplinary shared medical appointments for alopecia areata and frontal fibrosing alopecia
by: Ogechi Ezemma, et al.
Published: (2024)

Tick bite‐induced alopecia areata‐like effluvium
by: Rodrigo Peñuelas Leal, et al.
Published: (2024)

Update on pulse corticosteroid therapy for the management of alopecia areata
by: Jolina Bernhardt, et al.
Published: (2024)

Disseminated protothecosis: Case report and review of the literature
by: Safoura Shakoei, et al.
Published: (2024)

Scarring alopecia and nail loss in a patient with epidermolysis bullosa acquisita
by: Misaki Kusano, et al.
Published: (2024)

Comments on “Risk of autoimmune thyroid diseases in individuals with alopecia areata”
by: Brett R. Shaffer, et al.
Published: (2025)

European expert consensus statement on the systemic treatment of alopecia areata
by: L. Rudnicka, et al.
Published: (2024)

Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
by: Ieva Lingytė, et al.
Published: (2024)

Association of Janus kinase inhibitors with reduced depression in alopecia areata
by: Chih‐Yi Ho, et al.
Published: (2025)

Experiências afetivo-familiares de mulheres com alopecia areata
by: Renata Bilion Ruiz Prado
Published: (2008)

Comparing quality of life, anxiety, depression, sleep disturbance, and associated factors in vitiligo and alopecia areata patients
by: Fariba Ghalamkarpour, et al.
Published: (2024)

RETRACTED: Genetic association between asthma and alopecia areata: A two‐sample Mendelian randomization study
by: Wenqian Du, et al.
Published: (2024)

Hyalase in Dermatology: Applications Beyond Filler Management
by: Saba Hasanzadeh, et al.
Published: (2025)

Comorbilidades y factores asociados en pacientes con alopecia areata
by: Ana Lucía Jacas Portuondo
Published: (2022)

Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
by: M. Starace
Published: (2025)

Ultraviolet‐induced fluorescence dermoscopy in detecting follicular openings in alopecia areata
by: Xiaofan Jin, et al.
Published: (2025)

Posible relación entre alopecia areata e infecciones por enterovirus
by: S. Conde Barreiro
Published: (2014)

Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
by: John Frewen, et al.
Published: (2024)

A new era for alopecia areata: New treatments and improved knowledge of the condition
by: Bianca Maria Piraccini
Published: (2024)

More than cosmetic: A personal perspective on alopecia areata and therapeutic restoration
by: Catherine S. Taghizadeh, et al.
Published: (2026)

Stigmatizing attitudes towards facial psoriasis, atopic dermatitis, vitiligo and alopecia areata
by: Eleonora De Luca, et al.
Published: (2025)

A case of alopecia areata multiplex accompanied by chronic idiopathic thrombocytopenic purpura
by: Rina Obata, et al.
Published: (2024)

Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
by: Brett Hauber, et al.
Published: (2025)

Line‐field confocal optical coherence tomography in alopecia areata and histopathological correlation
by: Emanuele Trovato, et al.
Published: (2024)

Biologics and small molecules for patients with concomitant alopecia areata and vitiligo: A review
by: Eric McMullen, et al.
Published: (2024)

Pathogenesis of paradoxical alopecia areata during dupilumab therapy: What is known and unknown
by: Eric McMullen, et al.
Published: (2025)

SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
by: Ziad Reguiai, et al.
Published: (2025)